| OPERATING ACTIVITIES: | |
| Net income | -26M |
| Less: Income from discontinued operations, net of tax expense | |
| Income from continuing operations | |
| Adjustments to reconcile net income from continuing operations to net cash provided by operating activities from continuing operations: | |
| Depreciation and amortization expense | 53M |
| Amortization of long-term debt deferred financing costs | 2M |
| Amortization of debt premium and discount | 0 |
| Loss on extinguishment of debt | 1M |
| Non-cash convertible debt related expense | 7M |
| Stock-based compensation expense | 5M |
| Equity in net (income) loss from unconsolidated investments | 1M |
| Dividends from unconsolidated investments | |
| Deferred income taxes | -12M |
| Other, net | -5M |
| Change in restricted funds held in trust | |
| Change in working capital, net of effects of acquisitions | 33M |
| Total adjustments for continuing operations | 88M |
| Net cash provided by operating activities from continuing operations | |
| Net cash (used in) provided by operating activities from discontinued operations | |
| Net cash provided by operating activities | 62M |
| INVESTING ACTIVITIES: | |
| Proceeds from the sale of investment securities | 2M |
| Purchase of investment securities | -13M |
| Purchase of property, plant and equipment | -63M |
| Acquisition of noncontrolling interests in subsidiaries | -14M |
| Acquisition of businesses, net of cash acquired | |
| Loan issued for the Harrisburg EfW facility to fund certain facility improvements, net of repayments | |
| Acquisition of land use rights | 0 |
| Other, net | 1M |
| Net cash used in investing activities from continuing operations | |
| Net cash provided by (used in) investing activities from discontinued operations | |
| Net cash provided by (used in) investing activities | -87M |
| FINANCING ACTIVITIES: | |
| Principal payments on long-term debt | -1M |
| Principal payments on project debt | -16M |
| Proceeds from borrowings on project debt | |
| Change in restricted funds held in trust | -3M |
| Proceeds from the exercise of options for common stock, net | |
| Cash dividends paid to stockholders | 0 |
| Common stock repurchased | -24M |
| Distributions to partners of noncontrolling interests in subsidiaries | |
| Other, net | -12M |
| Net cash used in financing activities from continuing operations | |
| Net cash provided by (used in) financing activities from discontinued operations | |
| Net cash used in financing activities | -10M |
| Effect of exchange rate changes on cash and cash equivalents | 0 |
| Net increase (decrease) in cash and cash equivalents | -35M |
| Cash and cash equivalents at beginning of period | 246M |
| Cash and cash equivalents at end of period | 211M |
| Less: Cash and cash equivalents of discontinued operations at end of period | 0 |
| Cash and cash equivalents of continuing operations at end of period | 211M |